Sarepta Therapeutics(SRPT) - 2024 Q2 - Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Mary Jenkins - Associate Director, Investor Relations & Corporate Communications Doug Ingram - President & Chief Executive Officer Dallan Murray - Executive Vice President & Chief Customer Officer Louise Rodino-Klapac - Executive Vice President, Chief Scientific Officer & Head of Research & Development Ian Estepan - Executive Vice President & Chief Financial Officer Conference Call Partic ...